The Federal Government has revealed that the COVID Organics expected in the country from Madagascar would undergo “stringent” evaluation and processes before it could be prescribed to coronavirus patients in the country.
This was disclosed by the National Coordinator of the Presidential Task Force on COVID-19, Dr Sani Aliyu, during the briefing in Abuja on Tuesday.
Aliyu emphasised that no drug or vaccine would be used or distributed in the country without the certification of the National Agency for Food and Drug Administration and Control, NAFDAC.
He said, “I want to start briefly with the Madagascar cure because it has been in the press recently.
“As directed by Mr President, I want to state again that any medication coming into the country whether it’s a herbal cure or concoction or normal drug has to be subjected to the regulatory process.
“The Madagascar cure will be subjected to the regulatory process and guidelines that we have, not only to establish the drug efficacy but also drug safety.
“As stated by NAFDAC, no drug can be manufactured, imported, exported, advertised, sold or distributed in the country unless legally registered.
“So, this drug will go through the normal process which will be quite stringent before it can be administered to anybody within the country.”
Earlier, the PTF Chairman, Boss Mustapha, had said President Muhammadu Buhari had instructed the airlifting of the COVID Organics from Madagascar.